USRM Projected Dividend Yield

US Stem Cell Inc ( OTCBB : USRM )

U.S. Stem Cell is a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of disease and injury. Co. is also a medicine company focusing on physician/veterinary training and certification and stem cell products, stem cell banking, and the creation and management of stem cell clinics. Co.'s product candidate is MyoCell™, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells for the purpose of improving cardiac function in chronic heart failure patients. Co.'s product for in clinic use is Adipocell, a kit for the isolation of adipose derived stem cells.

20 YEAR PERFORMANCE RESULTS

USRM Dividend History Detail
USRM Dividend News
USRM Competitors News
# of Shares: 0 Closing Price: 0.00 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor